ATEZOLIZUMAB MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Atezolizumab Market, By Drug Class (PD-L1 Inhibitors, PD-1 Inhibitors, CTLA-4 Inhibitors, Immunomodulators, and Others), By Indication (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin’s Lymphoma, Head and Neck Cancer, and Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals, Homecare, Specialty Clinics, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 27 Mar, 2025
Code: CMI6228
Pages: 160
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range: 2020 - 2024
- Forecast Period: 2025 - 2032

N/A

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Atezolizumab, By Drug Class
  - Market Atezolizumab, By Indication
  - Market Atezolizumab, By Distribution Channel
  - Market Atezolizumab, By End User
  - Market Atezolizumab, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
    - Rising incidence of cancer globally
    - Increasing demand for effective treatment options
  - Restraints
    - High cost of atezolizumab
  - Opportunities
    - Ongoing research and development efforts by key players
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global Atezolizumab Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
Global Atezolizumab Market, By Drug Class, 2020-2032, (US$ Bn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- PD-L1 Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- PD-1 Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- CTLA-4 Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Immunomodulators
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Global Atezolizumab Market, By Indication, 2020-2032, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023and 2032 (%)
  - Y-o-Y Growth Analysis, 2021– 2032
  - Segment Trends
- Lung Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Bladder Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Melanoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Hodgkin’s Lymphoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Head and Neck Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Global Atezolizumab Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023and 2032 (%)
  - Y-o-Y Growth Analysis, 2021– 2032
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Global Atezolizumab Market, By
End User, 2020-2032, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023and 2032 (%)
  - Y-o-Y Growth Analysis, 2021– 2032
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Homecare
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Specialty Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Global Atezolizumab Market, By
Region, 2020-2032, (US$ Bn)
- Introduction
  - Market Share Analysis, By Country, 2023and 2032 (%)
  - Y-o-Y Growth Analysis, For Country 2021–2028
  - Country Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Middle East & Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Competitive Landscape
- Roche
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pfizer
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Merck
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AstraZeneca
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Bristol-Myers Squibb
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- BeiGene
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Innovent Biologics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Genentech
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- AbbVie
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Analyst Views
Section
- Research Methodology
- About us

*Browse 24 market data tables and 28 figures on "Global Atezolizumab Market” - Global forecast to 2032

Limited Time Offer - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now